BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26663790)

  • 1. Analysis of Cerebrospinal Fluid Carbohydrate Antigen Series Biomarkers in Non-neoplastic Diseases.
    Shi Q; Tian C; Huang X; Pu C
    Ann Clin Lab Sci; 2015; 45(6):623-6. PubMed ID: 26663790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline serum/cerebrospinal fluid ratio of carcinoembryonic antigen and carbohydrate antigen series biomarkers in non-neoplastic diseases: a cross-sectional study on 224 patients.
    Zhang Y; Ban R; Shi Q; Tian C
    Clin Biochem; 2019 Jan; 63():135-138. PubMed ID: 30403967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional Tumor Markers in Cerebralspinal Fluid in Patients with Elevated Serum Tumor Markers and without Central Nervous System Malignant Diseases.
    Liu ZJ; Shi Q; Lu B; Zhang Z; Tian CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):539-542. PubMed ID: 27825410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The determination of medical reference values for tumor markers in cerebrospinal fluid].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Cao XT
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):355-6. PubMed ID: 19563718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Cerebrospinal Fluid and Serum CEA Concentration in Non-neoplastic Diseases.
    Shi Q; Tian C; Huang X; Pu C
    Ann Clin Lab Sci; 2016; 46(2):180-3. PubMed ID: 27098625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
    Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
    Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
    Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tumor markers in hemodialysis patients.
    Maoujoud O; El Machtani S; Asseraji M; Atbib Y; Zajjari Y; Taoufik A; Elbouaiti E; Zouhair O; Benyahia M; Tellal S
    Int J Artif Organs; 2014 Feb; 37(2):126-32. PubMed ID: 24619900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
    Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
    Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF and serum hCG in patients without gestational and neoplastic hCG-secretion.
    Tian C; Shi Q; Xiao G; Pu C; Huang X; Yu S; Zhang J
    Scand J Clin Lab Invest; 2011 Jul; 71(4):264-8. PubMed ID: 21309644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilution effect of serum CA125 and CA19-9 over a cutoff value, according to obesity.
    Kim JH; Park BR; Yang WJ
    Int J Biol Markers; 2015 Feb; 30(1):e122-6. PubMed ID: 25262704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis.
    Shen A; Xu S; Ma Y; Guo H; Li C; Yang C; Zou S
    J Int Med Res; 2015 Oct; 43(5):599-609. PubMed ID: 26246541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tumour markers in patients with chronic kidney disease.
    Xiaofang Y; Yue Z; Xialian X; Zhibin Y
    Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF and serum AFP in patients without gestational or neoplastic AFP-secretion.
    Shi Q; Tian C; Pu C; Yu S; Huang X
    Scand J Clin Lab Invest; 2012 Dec; 72(8):619-22. PubMed ID: 23020232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.